Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

1983-12-31

Original market date: See footnote 1

1983-12-31

Product name:

VIADERM KC ONT

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00717029

Product Monograph/Veterinary Labelling:

Date: 2018-07-05 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

TARO PHARMACEUTICALS INC
130 East Drive
Brampton
Ontario
Canada  L6T 1C1

Class: 

Human

Dosage form(s):

Ointment

Route(s) of administration:

Topical

Number of active ingredient(s):

4

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

84:06.00   ANTI-INFLAMMATORY AGENTS ,  84:04.04   ANTIBIOTICS

Anatomical Therapeutic Chemical (ATC): See footnote 4

D07CB01  TRIAMCINOLONE AND ANTIBIOTICS

Active ingredient group (AIG) number:See footnote 5

0405625002

List of active ingredient(s)
Active ingredient(s) Strength
GRAMICIDIN 0.25 MG / G
NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG / G
NYSTATIN 100000 UNIT / G
TRIAMCINOLONE ACETONIDE 1 MG / G

Application information

Related information

Contact us

Version 3.9.0
Date modified: